Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Staib

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Eukaryotic Cell|December 23, 2008
Gene expression profiling in the human pathogenic dermatophyte Trichophyton rubrum during growth on proteinsChristophe Zaugg, Michel Monod, Johann Weber, et al.
Chemmedchem|November 27, 2007
Cis-Configured aziridines are new pseudo-irreversible dual-mode inhibitors of Candida albicans secreted aspartic protease 2Björn Degel, Peter Staib, Sebastian Rohrer, et al.
Archives of Dermatological Research|April 28, 2016
Development and validation of the Patient Benefit Index for the dermatocosmetic treatment of aged skinDavid Lohrberg, Jürgen Blaak, Juliane Liebsch, et al.
Proteomics|September 16, 2011
Identification of novel secreted proteases during extracellular proteolysis by dermatophytes at acidic pHDev Sriranganadane, Patrice Waridel, Karine Salamin, et al.
Skin Pharmacology and Physiology|August 18, 2015
A Long-Term Study to Evaluate Acidic Skin Care Treatment in Nursing Home Residents: Impact on Epidermal Barrier Function and Microflora in Aged SkinJürgen Blaak, Olaf Kaup, Willi Hoppe, et al.
Cancers|November 13, 2025
Delay of Systemic Therapy Confers a Survival Benefit in Patients with Stage IV Non-Small-Cell Lung CancerRike Geiken-Weinstock, Frank Griesinger, Michael Metz, et al.
Immunology Letters|August 27, 2015
Secreted aspartic protease 2 of Candida albicans inactivates factor H and the macrophage factor H-receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18)Eliška Svoboda, Andrea E Schneider, Noémi Sándor, et al.
Cancer Medicine|August 26, 2022
Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non-interventional study MabSCaleJan Dürig, Jens Uhlig, Anke Gerhardt, et al.
European Journal of Haematology|December 11, 2008
Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cellsKatharina Salome Minke, Peter Staib, Adriane Puetter, et al.
Cancer Immunology, Immunotherapy : CII|October 24, 2012
Clinical safety and pharmacological profile of the HLA-DR antibody 1D09C3 in patients with B cell chronic lymphocytic leukemia and lymphoma: results from a phase I studyCarmen D Schweighofer, Armin Tuchscherer, Sabine Sperka, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Eukaryotic Cell|December 23, 2008
Gene expression profiling in the human pathogenic dermatophyte Trichophyton rubrum during growth on proteinsChristophe Zaugg, Michel Monod, Johann Weber, et al.
Chemmedchem|November 27, 2007
Cis-Configured aziridines are new pseudo-irreversible dual-mode inhibitors of Candida albicans secreted aspartic protease 2Björn Degel, Peter Staib, Sebastian Rohrer, et al.
Archives of Dermatological Research|April 28, 2016
Development and validation of the Patient Benefit Index for the dermatocosmetic treatment of aged skinDavid Lohrberg, Jürgen Blaak, Juliane Liebsch, et al.
Proteomics|September 16, 2011
Identification of novel secreted proteases during extracellular proteolysis by dermatophytes at acidic pHDev Sriranganadane, Patrice Waridel, Karine Salamin, et al.
Skin Pharmacology and Physiology|August 18, 2015
A Long-Term Study to Evaluate Acidic Skin Care Treatment in Nursing Home Residents: Impact on Epidermal Barrier Function and Microflora in Aged SkinJürgen Blaak, Olaf Kaup, Willi Hoppe, et al.
Cancers|November 13, 2025
Delay of Systemic Therapy Confers a Survival Benefit in Patients with Stage IV Non-Small-Cell Lung CancerRike Geiken-Weinstock, Frank Griesinger, Michael Metz, et al.
Immunology Letters|August 27, 2015
Secreted aspartic protease 2 of Candida albicans inactivates factor H and the macrophage factor H-receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18)Eliška Svoboda, Andrea E Schneider, Noémi Sándor, et al.
Cancer Medicine|August 26, 2022
Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non-interventional study MabSCaleJan Dürig, Jens Uhlig, Anke Gerhardt, et al.
European Journal of Haematology|December 11, 2008
Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cellsKatharina Salome Minke, Peter Staib, Adriane Puetter, et al.
Cancer Immunology, Immunotherapy : CII|October 24, 2012
Clinical safety and pharmacological profile of the HLA-DR antibody 1D09C3 in patients with B cell chronic lymphocytic leukemia and lymphoma: results from a phase I studyCarmen D Schweighofer, Armin Tuchscherer, Sabine Sperka, et al.
Pageof 9